We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amarin Patent Lawsuit Against Hikma, Health Net Can Proceed, Judge Says
Amarin Patent Lawsuit Against Hikma, Health Net Can Proceed, Judge Says
A federal court in Delaware has rejected a motion by Hikma Pharmaceuticals to dismiss Amarin Pharma’s patent lawsuit over Hikma’s generic version of the heart drug Vascepa (icosapent ethyl).